PRESS RELEASE published on 03/12/2024 at 06:55, 2 years ago Operationally successful FY 2023 for TAG; sales results in Poland exceed guidance; significantly increased net liquidity from disposals in Germany; LTV stable despite portfolio devaluation TAG Immobilien AG reports successful FY 2023 with sales in Poland surpassing guidance and increased net liquidity from German disposals. LTV remains stable despite portfolio devaluation FY 2023 TAG Immobilien AG Sales Results Net Liquidity Portfolio Devaluation
PRESS RELEASE published on 03/12/2024 at 06:45, 2 years ago Galenica poursuit sa croissance au cours de l’exercice 2023 Le Groupe Galenica a enregistré une forte croissance du chiffre d'affaires de 4.4% au cours de l'exercice 2023 et prévoit une hausse de 8% à 11% pour l'EBIT ajusté en 2024. Détails dans le Rapport annuel 2023 Chiffre D'affaires Croissance EBIT Ajusté Rapport Annuel 2023 Galenica
PRESS RELEASE published on 03/12/2024 at 06:45, 2 years ago Galenica continues to grow in the 2023 financial year Galenica Group achieves 4.4% sales growth in 2023, proposing stable dividend. Expects 3-5% sales growth in 2024, increased adjusted EBIT by 8-11% 2024 Outlook Sales Growth Dividend Proposal Galenica Group Adjusted EBIT Increase
PRESS RELEASE published on 03/12/2024 at 06:45, 2 years ago PolyPeptide with record revenue growth of 43% in H2 2023 versus H1 2023; operational improvements yielding increased profitability and cash flow PolyPeptide announces record revenue growth of 43% in H2 2023 compared to H1 2023, along with enhanced profitability and cash flow. Details on 2023 results and 2024 guidance provided Revenue Growth Cash Flow Profitability 2023 Results PolyPeptide
PRESS RELEASE published on 03/12/2024 at 06:30, 2 years ago Medartis increases sales by 21% (CER) and improves its underlying EBITDA margin to 16%
PRESS RELEASE published on 03/12/2024 at 06:30, 2 years ago Affluent Medical annonce le succès de la première implantation chez l’homme de son sphincter artificiel Artus pour le traitement de l’incontinence urinaire d’effort. Affluent Medical annonce le succès de la première implantation chez l'homme de son sphincter artificiel Artus pour le traitement de l'incontinence urinaire d'effort Affluent Medical Dispositif Médical Incontinence Urinaire Artus Implantation
PRESS RELEASE published on 03/12/2024 at 06:30, 2 years ago Affluent Medical announces successful first-in-human implantation of its artificial sphincter Artus for the treatment of stress urinary incontinence. Affluent Medical announces successful first-in-human implantation of its artificial sphincter Artus for the treatment of stress urinary incontinence in Prague, Czech Republic. The innovative medical device offers hope for the estimated 400 million patients affected worldwide Medical Device Affluent Medical Urinary Incontinence Artus First-in-human Implantation
PRESS RELEASE published on 03/12/2024 at 06:20, 2 years ago Sensirion Holding AG: Challenging 2023 due to the ongoing slump in consumption and global inventory corrections; Returning to growth path in 2024 Sensirion Holding AG faces challenges in 2023 with a decline in sales due to weak demand and inventory corrections, but anticipates a return to growth in 2024 supported by new product launches and market opportunities Sales Decline Product Launches Sensirion Holding AG Inventory Corrections Return To Growth
PRESS RELEASE published on 03/12/2024 at 00:25, 2 years ago bettermoo(d) Provides Details of the Special Investors Announcement on Wednesday, March 13, 2024 bettermoo(d) Food Corporation announces details for special investors announcement regarding a new development to be shared by CEO Nima Bahrami. Conference call scheduled for March 13, 2024, with press release following. Company focuses on innovative plant-based dairy-alternative products Bettermoo(d) Food Corporation Dairy Alternative Moodrink Investors Announcement Nima Bahrami
PRESS RELEASE published on 03/11/2024 at 23:15, 2 years ago Boron One Announces Successful Closing of Early Warrant Exercise Incentive Program Boron One Holdings Inc. announces the successful closing of its warrant exercise incentive program, with 3,933,363 warrants exercised for proceeds of $354,002.67, enhancing working capital TSX Venture Exchange Common Shares Working Capital Boron One Holdings Inc. Warrant Exercise Incentive Program
Published on 03/26/2026 at 08:05, 1 hour 38 minutes ago Vanta Announces U.S. Ticker Symbol Change to VNTXF
Published on 03/26/2026 at 04:55, 4 hours 48 minutes ago Vanta Announces Capital Markets Initiatives to Strengthen Financial Position and Support Growth Initiatives
Published on 03/26/2026 at 00:40, 9 hours 3 minutes ago Challenger RC Resource Upgrade Drilling Complete
Published on 03/26/2026 at 00:30, 9 hours 13 minutes ago Nano One Highlights Recent Objectives & Reports Fourth Quarter 2025 Results
Published on 03/25/2026 at 19:15, 14 hours 28 minutes ago Gemina Laboratories Ltd. Announces Delisting from the CSE
Published on 03/26/2026 at 09:35, 8 minutes ago BORICA Reveals How Bulgaria Executed Euro Payments Cutover at National Scale in Partnership with OpenWay
Published on 03/26/2026 at 09:20, 23 minutes ago yoummday Wins a Texas Instruments 2025 Supplier Excellence Award
Published on 03/26/2026 at 09:05, 38 minutes ago Rockwell Automation Showcases Autonomous Industrial Operations at Hannover Messe 2026
Published on 03/26/2026 at 09:00, 42 minutes ago Original-Research: ZEAL Network SE (von NuWays AG): BUY
Published on 03/26/2026 at 07:30, 2 hours 13 minutes ago BIOPHYTIS-LYNXKITE ALLIANCE INVITED TO NVIDIA CONFERENCE: UNLEASHING AI TO REVOLUTIONIZE LONGEVITY
Published on 03/26/2026 at 07:30, 2 hours 13 minutes ago BIOPHYTIS ET LYNXKITE INVITÉS À LA CONFÉRENCE NVIDIA : L’IA AU SERVICE DE LA LONGÉVITÉ
Published on 03/25/2026 at 18:53, 14 hours 49 minutes ago CIS - Transfert Contrat de Liquidité Portzamparc - 25.03.2026